Maria del Puerto C. A.
- Country
- Spain
- Department
- Servicio de Neumologia
Research Overview
- Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Anti-TSLP Antibody GSK5784283 in Adults with Uncontrolled Asthma
- A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- Efficacy and Safety Evaluation of Benralizumab in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease with Frequent Exacerbations
Data & Insights
Has run more than one trial at 32 of 223 partner sites.
Specializations
Respiratory Disease Management
The investigator specializes in treating severe respiratory conditions, with particular focus on Chronic Obstructive Pulmonary Disease (COPD) and its management in patients with frequent exacerbations.
- Moderate to Very Severe COPD
- COPD Exacerbation Prevention
- Blood Eosinophil-Related COPD
Their research extends to investigating innovative therapeutic approaches for COPD patients with elevated peripheral blood eosinophils.
Asthma Treatment Innovation
The investigator conducts research in uncontrolled asthma treatment, focusing on novel therapeutic approaches for adult patients with persistent symptoms.
- Adult Asthma Management
- Biomarker Assessment
- Respiratory Function Evaluation
Their work includes evaluation of respiratory biomarkers such as fraction of exhaled nitric oxide (FeNO) in asthma patients.
Respiratory Biomarkers
The investigator's expertise encompasses the study of respiratory inflammatory markers and their role in disease monitoring and treatment response.
- Inflammatory Biomarker Analysis
- Disease Monitoring Techniques
- Treatment Response Assessment
Their research includes evaluation of various biomarkers for respiratory disease management and treatment optimization.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.